Literature DB >> 20439328

Ethical and existential challenges associated with a cancer diagnosis.

Jan Pascal1, Ruth Endacott.   

Abstract

BACKGROUND: At the point of cancer diagnosis, practitioners may wrestle with ethical dilemmas associated with medico-legal implications of diagnosis, treatment options and disclosure to family members. The patient's perspective can take a different route, focusing on ethical and existential questions about the value and purpose of life, culminating in the question: how do I lead my life after diagnosis?
OBJECTIVE: To explore the ethical and existential challenges associated with a cancer diagnosis from the perspective of cancer survivors.
DESIGN: Qualitative design using specifically phenomenological methods to enable focus on subjective experience. Two in-depth interviews were conducted over a 6-month period.
SETTING: Bendigo, Victoria, Australia. PARTICIPANTS: 15 participants (n=11 women and n=4 men) volunteered to be interviewed. Age ranged from 32 to 85 years of age; length of survival 0.5-25 years; with a range of cancer diagnoses.
RESULTS: Findings demonstrated that participants experienced existential and ethical challenges associated with a cancer diagnosis and subsequent survivorhood. These challenges were present regardless of cancer stage or diagnostic type and pervaded throughout length of survival. The existential challenges included the experience of anxiety and uncertainty about recurrence and metastatic disease. In particular, participants reported iatrogenic uncertainty induced by tests and treatment with follow-up regimes underscoring the fragility of survivor status. Uncertainty served as a 'wake-up call' and precipitated ethical challenges. Such challenges involved making meaning of survivorhood and questioning of morals, values and relationships. At times these questions were painful and difficult, creating unease about leading a 'good' and purposeful life. Entering ethically rocky terrain was also considered identity enhancing, with reports that a cancer diagnosis could have benefits as well as challenges.
CONCLUSION: This study identified a number of challenges associated with a cancer diagnosis; these have implications for the preparation of medical, nursing and social work practitioners and should be considered during the design of follow-up support for cancer patients and those in recovery.

Entities:  

Mesh:

Year:  2010        PMID: 20439328     DOI: 10.1136/jme.2009.034942

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  6 in total

1.  Existential challenges experienced by lymphoma survivors: Results from the 2010 LIVESTRONG Survey.

Authors:  Donna M Posluszny; Mary Amanda Dew; Ellen Beckjord; Dana H Bovbjerg; John E Schmidt; Carissa A Low; Amy Lowery; Stephanie A Nutt; Sarah R Arvey; Ruth Rechis
Journal:  J Health Psychol       Date:  2015-04-06

2.  Development of an "Impact of HIV" Instrument for HIV Survivors.

Authors:  April L Buscher; Michael A Kallen; Maria E Suarez-Almazor; Thomas P Giordano
Journal:  J Assoc Nurses AIDS Care       Date:  2015-08-14       Impact factor: 1.354

Review 3.  Clinical considerations for working with patients with advanced cancer.

Authors:  Megan Taylor-Ford
Journal:  J Clin Psychol Med Settings       Date:  2014-09

4.  Ethical challenges in family caregivers of patients with advanced cancer - a qualitative study.

Authors:  Anneke Ullrich; Marianna Theochari; Corinna Bergelt; Gabriella Marx; Katharina Woellert; Carsten Bokemeyer; Karin Oechsle
Journal:  BMC Palliat Care       Date:  2020-05-18       Impact factor: 3.234

Review 5.  Heideggerian hermeneutic phenomenology as method: modelling analysis through a meta-synthesis of articles on Being-towards-death.

Authors:  Janice Gullick; Sandra West
Journal:  Med Health Care Philos       Date:  2020-03

6.  Meanings of existential uncertainty and certainty for people diagnosed with cancer and receiving palliative treatment: a life-world phenomenological study.

Authors:  Magdalena Karlsson; Febe Friberg; Catarina Wallengren; Joakim Ohlén
Journal:  BMC Palliat Care       Date:  2014-06-11       Impact factor: 3.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.